BiomEdit / Patents and Publications

Peer-reviewed science and protected IP behind our platform

From strain engineering to field performance, our work is published in peer-reviewed scientific journals and covered by a comprehensive intellectual property (IP) strategy.

Peer-reviewed publications from our scientists.

Recombinant Limosilactobacillus reuteri strains expressing nanobodies against Clostridium perfringens toxins improve broiler performance during subclinical necrotic enteritis challenge

Journal of Applied Poultry Research — September 7, 2026

Lactobacillus-vectored nanobodies improve broiler productivity under sub-clinical necrotic enteritis with associated microbiome and transcriptome changes

npj Biofilms and Microbiomes — January 14, 2026

Interactions between time on diet, antibiotic treatment, and liver abscess development on the fecal microbiome of beef cattle

Animal Microbiome — May 12, 2025

Designing host-associated microbiomes using the consumer/resource model

mSystems — January 21, 2025

Effects of Limosilactobacillus reuteri strains PTA-126787 and PTA-126788 on intestinal barrier integrity and immune homeostasis in an alcohol-induced leaky gut model

Scientific Reports — August 23, 2024

Evolving understanding of rumen methanogen ecophysiology

Frontiers in Microbiology — November 6, 2023

In silico, in vitro and in vivo characterization of host-associated Latilactobacillus curvatus strains for potential probiotic applications in farmed Atlantic salmon (Salmo salar)

Scientific Reports — November 1, 2022

Transcriptome Analyses of Chicken Primary Macrophages Infected With Attenuated Salmonella Typhimurium Mutants

Frontiers in Microbiology — May 3, 2022

Growth promotion and antibiotic induced metabolic shifts in the chicken gut microbiome

Communications Biology — April 1, 2022

Recombinant Limosilactobacillus (Lactobacillus) delivering nanobodies against Clostridium perfringens NetB and alpha toxin confers potential protection from necrotic enteritis

MicrobiologyOpen — March 16, 2022

In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications

PLoS ONE — January 26, 2022

Multi-Omics Characterization of Host-Derived Bacillus spp. Probiotics for Improved Growth Performance in Poultry

Frontiers in Microbiology — October 20, 2021

A selection of patents securing our Programmable Veterinary Biologics™ platform.

BiomEdit has been issued several patents over the past four years, including two recent U.S. patents: “Genetically Modified Lactobacillus and Uses Thereof” (U.S. Patent 12,599,637) and “Probiotic Compositions Comprising Lactobacillus reuteri Strains and Methods of Use” (U.S. Patent 12,427,174). Each establishes protection for engineered Lactobacillus reuteri strains, including composition of matter and methods of use, and systems used to deliver biologically active molecules directly within the host. These patents are part of our Programmable Veterinary Biologics platform.

U.S. Patent 12,599,637

“Genetically Modified Lactobacillus and Uses Thereof”

U.S. Patent 12,427,174

“Probiotic Compositions Comprising Lactobacillus reuteri Strains and Methods of Use”

These two patents cover:

  • Engineered Lactobacillus reuteri strains capable of expressing therapeutic biomolecules in situ.
  • Delivery systems enabling localized and sustained payload expression.
  • Expression of biologically active proteins, including novel antibodies targeting Clostridium perfringens, a significant pathogen in animal health.
  • Applications across multiple species, spanning livestock, pets and human health.

Want to learn more about BiomEdit?